- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Quantifying beta cell function in the preclinical stages of type 1 diabetes ; volume:66 ; number:12 ; day:15 ; month:9 ; year:2023 ; pages:2189-2199 ; date:12.2023
Diabetologia ; 66, Heft 12 (15.9.2023), 2189-2199, 12.2023
- Creator
-
Galderisi, Alfonso
Carr, Alice L. J.
Martino, Mariangela
Taylor, Peter
Senior, Peter
Dayan, Colin
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00125-023-06011-5
- URN
-
urn:nbn:de:101:1-2024012309055220749959
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:29 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Galderisi, Alfonso
- Carr, Alice L. J.
- Martino, Mariangela
- Taylor, Peter
- Senior, Peter
- Dayan, Colin
- SpringerLink (Online service)
Other Objects (12)
Latter-stage preclinical developmental work on PL69/DM1157
L-Arginine in diabetes: clinical and preclinical evidence
P2.51 Preclinical Atherosclerotic Disease and Metabolic Syndrome: A Prediabetes Stage?
Correction: L-Arginine in diabetes: clinical and preclinical evidence
Quantifying the Life Stages of a Biomolecule: Implications for the Circadian Transcriptome
Beta-blockers and glioma: a systematic review of preclinical studies and clinical results
Brain reserve contributes to distinguishing preclinical Alzheimer’s stages 1 and 2
Preclinical carotid atherosclerosis in patients with latent autoimmune diabetes in adults (LADA), type 2 diabetes and classical type 1 diabetes
Preclinical hyperthermia
Die Serum-Beta-Glukuronidase-Aktivität bei Diabetes mellitus
Trajectory of beta cell function and insulin clearance in stage 2 type 1 diabetes: natural history and response to teplizumab
Regional myocardial function at preclinical disease stage of hypertrophic cardiomyopathy in female gene variant carriers
Latter-stage preclinical developmental work on PL69/DM1157
L-Arginine in diabetes: clinical and preclinical evidence
P2.51 Preclinical Atherosclerotic Disease and Metabolic Syndrome: A Prediabetes Stage?
Correction: L-Arginine in diabetes: clinical and preclinical evidence
Quantifying the Life Stages of a Biomolecule: Implications for the Circadian Transcriptome
Beta-blockers and glioma: a systematic review of preclinical studies and clinical results
Brain reserve contributes to distinguishing preclinical Alzheimer’s stages 1 and 2
Preclinical carotid atherosclerosis in patients with latent autoimmune diabetes in adults (LADA), type 2 diabetes and classical type 1 diabetes
Preclinical hyperthermia
Die Serum-Beta-Glukuronidase-Aktivität bei Diabetes mellitus
Trajectory of beta cell function and insulin clearance in stage 2 type 1 diabetes: natural history and response to teplizumab
Regional myocardial function at preclinical disease stage of hypertrophic cardiomyopathy in female gene variant carriers
Latter-stage preclinical developmental work on PL69/DM1157
L-Arginine in diabetes: clinical and preclinical evidence
P2.51 Preclinical Atherosclerotic Disease and Metabolic Syndrome: A Prediabetes Stage?
Correction: L-Arginine in diabetes: clinical and preclinical evidence
Quantifying the Life Stages of a Biomolecule: Implications for the Circadian Transcriptome
Beta-blockers and glioma: a systematic review of preclinical studies and clinical results
Brain reserve contributes to distinguishing preclinical Alzheimer’s stages 1 and 2
Preclinical carotid atherosclerosis in patients with latent autoimmune diabetes in adults (LADA), type 2 diabetes and classical type 1 diabetes
Preclinical hyperthermia
Die Serum-Beta-Glukuronidase-Aktivität bei Diabetes mellitus
Trajectory of beta cell function and insulin clearance in stage 2 type 1 diabetes: natural history and response to teplizumab